You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Her-2/Neu

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Detroit (biological, drug, other)

Terminated
Has Results
  • Breast Cancer
  • HER2Bi-armed activated T cells
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 29, 2022

Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

Completed
Has Results
  • Breast Neoplasms
  • +3 more
  • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022

Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

Recruiting
  • Breast Cancer
  • HER2-positive
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Breast Cancer Trial in United States (Placebo, GLSI-100)

Recruiting
  • Breast Cancer
  • Placebo
  • GLSI-100
  • Birmingham, Alabama
  • +21 more
Jan 30, 2023

Metastatic Breast Cancer Trial in Charlottesville (HER2 BATs with Pembrolizumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 BATs with Pembrolizumab
  • Charlottesville, Virginia
    Ashley Donihee
Jan 18, 2023

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,

Not yet recruiting
  • Gastric Cancer
  • +5 more
  • IMU-131
  • +2 more
  • Woodville South, South Australia, Australia
    The Queen Elizabeth Hospital
Apr 12, 2022

Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)

Terminated
  • Breast Cancer Female
  • Leptomeningeal Metastases
  • HER2 BATs
  • Charlottesville, Virginia
    University of Virginia
Dec 15, 2022

Breast, Metastatic, Triple Negative Trial in Gainesville, Jacksonville (Capecitabine, Sarilumab 150mg or 200 mg plus

Active, not recruiting
  • Breast
  • +4 more
  • Gainesville, Florida
  • +1 more
Feb 2, 2023

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

HER2/Neu+ Uterine Serous Carcinoma Trial in Tucson, New Haven, Boston (Afatinib)

Recruiting
  • HER2/Neu+ Uterine Serous Carcinoma
  • Tucson, Arizona
  • +2 more
Feb 2, 2022

Bilateral Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Oak Lawn, Houston (Best Practice, Ixabepilone)

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +2 more
  • Oak Lawn, Illinois
  • +2 more
Mar 10, 2022

Breast Cancer Trial in Duarte, Columbus (omega 3 fatty acids)

Active, not recruiting
  • Breast Cancer
  • omega 3 fatty acids
  • Duarte, California
  • +1 more
Jun 8, 2022

Breast Cancer Stage IV Trial in Clackamas, Newberg, Portland (Tucatinib)

Recruiting
  • Breast Cancer Stage IV
  • Clackamas, Oregon
  • +3 more
Jan 12, 2022

Adenocarcinoma - GEJ, Adenocarcinoma of the Stomach Trial in Bengbu (HER2 Tumor Vaccine, HER2 Tumor Vaccine+ Standard of Care

Recruiting
  • Adenocarcinoma - GEJ
  • Adenocarcinoma of the Stomach
  • HER2 Tumor Vaccine
  • HER2 Tumor Vaccine+ Standard of Care chemotherapy
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Apr 6, 2022

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Tumor Metastasis Trial in New York (Intra-arterial Cerebral Infusion of Trastuzumab)

Terminated
  • Neoplasm Metastasis
  • Intra-arterial Cerebral Infusion of Trastuzumab
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

Recruiting
  • Carcinoma Breast Stage I
  • HER2 Positive Breast Cancer
  • Mumbai, India
    Tata Memorial Centre
Apr 26, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Metastatic Breast Cancer Trial in Baltimore (Trastuzumab plus Pertuzumab, Hormonal Therapy with Anastrozole and Fulvestrant,

Terminated
Has Results
  • Metastatic Breast Cancer
  • Trastuzumab plus Pertuzumab
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
May 4, 2022

Breast Cancer Trial in Omaha (Palbociclib 125mg)

Recruiting
  • Breast Cancer
  • Palbociclib 125mg
  • Omaha, Nebraska
    Nebraska Medicine
Mar 3, 2022

Locally Advanced Breast Cancer Trial in New York (Docetaxel, Carboplatin, Trastuzumab)

Terminated
  • Locally Advanced Breast Cancer
  • New York, New York
  • +2 more
Oct 18, 2021

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023